For investors active in ATMPs and biologics, regulatory maturity, CMC readiness and aligned agency strategy are decisive factors for risk allocation, valuation and exit timing.
Starodub BV delivers independent, senior regulatory due diligence to support investment decisions and portfolio oversight. We provide clear, objective assessments of regulatory readiness, critical gaps and risk mitigation pathways aligned with EMA/FDA expectations.
Starodub offers:
- Deep expertise in ATMPs, biologics & advanced therapies
- Regulatory strategy
- Due diligence with objective gap and risk assessments and actionable recommendations
- Fast, hands-on support when milestones matter most
Contact us via [email protected] to assess regulatory readiness, reduce execution risk and protect portfolio value.
